Are there any supporting studies or clinical findings that can help set expectations for results?

Yes. The key ingredients in Selentra HP™ have been evaluated in human clinical studies.

VMK223™ was evaluated in a 12-week, placebo-controlled study of women ages 40–55. Researchers observed statistically significant changes in biomarkers associated with healthy immune function, along with changes in certain hormone-related measures. A follow-up study also reported improvements in skin hydration, elasticity, and overall appearance.†

OsteoCaf™ was evaluated in a one-year clinical study of postmenopausal women, where researchers observed support for healthy bone mineral density at the same daily amount included in Selentra HP™.†

Individual responses may vary. In clinical research, some benefits were observed within approximately 4 weeks, with additional changes reported over 8–12 weeks of consistent use.†

If you are a healthcare practitioner, please log in to your practitioner account and explore the HCP resources under the Practitioner tab for access to additional studies, clinical insights, and past webinar recordings from expert speakers.